According to Edwards Lifesciences's latest financial reports the company's total debt is C$0.95 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | C$1.00 B | 10.54% |
2023-12-31 | C$0.90 B | -3.13% |
2022-12-31 | C$0.93 B | 6.63% |
2021-12-31 | C$0.87 B | -0.71% |
2020-12-31 | C$0.88 B | -0.06% |
2019-12-31 | C$0.88 B | 9.6% |
2018-12-31 | C$0.80 B | -37.92% |
2017-12-31 | C$1.30 B | 17.91% |
2016-12-31 | C$1.10 B | 33.46% |
2015-12-31 | C$0.82 B | 19.3% |
2014-12-31 | C$0.69 B | 9.94% |
2013-12-31 | C$0.63 B | 235.4% |
2012-12-31 | C$0.18 B | 23.04% |
2011-12-31 | C$0.15 B | 266.14% |
2010-12-31 | C$41.78 M | -56.02% |
2009-12-31 | C$95.01 M | -55.47% |
2008-12-31 | C$0.21 B | 1.04% |
2007-12-31 | C$0.21 B | -23.11% |
2006-12-31 | C$0.27 B | -25.37% |
2005-12-31 | C$0.36 B | 14.71% |
2004-12-31 | C$0.32 B | -3.32% |
2003-12-31 | C$0.33 B | -14.42% |
2002-12-31 | C$0.38 B | -21.71% |
2001-12-31 | C$0.49 B | -22.76% |
2000-12-31 | C$0.64 B |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() Boston Scientific BSX | C$15.92 B | 1,574.01% | ๐บ๐ธ USA |
![]() Merit Medical MMSI | C$1.11 B | 16.91% | ๐บ๐ธ USA |
![]() LeMaitre Vascular LMAT | C$0.25 B | -73.50% | ๐บ๐ธ USA |
![]() CryoLife CRY | N/A | N/A | ๐บ๐ธ USA |
![]() Medtronic MDT | C$36.19 B | 3,704.26% | ๐ฎ๐ช Ireland |
![]() ICU Medical
ICUI | C$2.17 B | 128.83% | ๐บ๐ธ USA |